Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jul 27, 2016 at 7:50 AM EDT

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected…

Chris Lange | Jul 26, 2016 at 11:50 AM EDT

Why Analysts Are Thinking M&A Is Back on the Table for Gilead

Overall, the Gilead Sciences report was not good and investors took to dumping the stock. On the other hand, this…

Chris Lange | Jul 26, 2016 at 10:10 AM EDT

Why Eli Lilly Earnings Are So Dynamic

As one of the largest pharmaceutical companies on the street, Eli Lilly helps to set the tempo for the industry.…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Chris Lange | Jul 25, 2016 at 4:37 PM EDT

Why Analysts Were Not Satisfied With Gilead Earnings

Although Gilead Sciences is one of the world’s leading biotech companies, an earnings beat in its latest report was not…

Chris Lange | Jul 25, 2016 at 9:05 AM EDT

What to Expect From Gilead Sciences Earnings

Gilead Sciences is scheduled to release its second-quarter financial results after the markets close on Monday.

Douglas A. McIntyre | Jul 23, 2016 at 9:55 AM EDT

UnitedHealth Up 22%, Leads Dow in 2016

One key reason UnitedHealth has done well is that it has managed the downward pressure Obamacare has put on may…

Chris Lange | Jul 22, 2016 at 11:10 AM EDT

Is This the Turning Point Puma Biotech Investors Have Waited For?

Puma Biotechnology watched its shares make a handy gain on Friday morning after the firm released updated results from its…

Chris Lange | Jul 21, 2016 at 10:10 AM EDT

Why the Relypsa Merger Is a Great Idea

Relypsa made a splash in the markets on Thursday morning after the company announced an acquisition agreement.

Chris Lange | Jul 20, 2016 at 10:05 AM EDT

Could This Be the Turning Point for Progenics and Valeant?

Shares of Progenics Pharmaceuticals and Valeant Pharmaceuticals made handy gains in the market on Wednesday following a key FDA approval…

Chris Lange | Jul 19, 2016 at 9:25 AM EDT

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

As one of the largest health care companies on the market, Johnson & Johnson helps set a direction for the…

Paul Ausick | Jul 19, 2016 at 8:20 AM EDT

UnitedHealth Lifts Low-End of EPS Forecast After Solid Earnings

When UnitedHealth Group reported second-quarter 2016 results before markets opened Tuesday, it also updated its full-year earnings guidance.

Chris Lange | Jul 18, 2016 at 10:25 AM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is set to release its second-quarter earnings report before the markets open on Tuesday, a period in…

Jon C. Ogg | Jul 17, 2016 at 10:35 AM EDT

4 Speculative Biotech and Biohealth Analysts Calls for Huge Upside

Investors in the biotech and biohealth space generally are taking on much more risk than in the likes of most…

Chris Lange | Jul 16, 2016 at 9:20 AM EDT

Synergy Pharmaceuticals Sinks on FDA Update

Investor reaction to Synergy Pharmaceuticals reaching the FDA mid-cycle review milestone for the plecanatide new drug application in chronic idiopathic…

1 … 201 202 203 204 205 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biotechs See Increased Short Interest Bets

Why Analysts Are Thinking M&A Is Back on the Table for Gilead

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Why Analysts Were Not Satisfied With Gilead Earnings

What to Expect From Gilead Sciences Earnings

UnitedHealth Up 22%, Leads Dow in 2016

Is This the Turning Point Puma Biotech Investors Have Waited For?

Why the Relypsa Merger Is a Great Idea

Could This Be the Turning Point for Progenics and Valeant?

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

UnitedHealth Lifts Low-End of EPS Forecast After Solid Earnings

What to Look for in Johnson & Johnson Earnings

4 Speculative Biotech and Biohealth Analysts Calls for Huge Upside

Synergy Pharmaceuticals Sinks on FDA Update

Prediction: Elon Musk Will Target 2 Trillion-Dollar Acquisitions After the SpaceX IPO

SpaceX IPOs on Friday. The 55% rule says don’t chase it.

‘Don’t Blame Your Stupidity on Christianity’: Dave Ramsey’s Blunt Advice to a Bride Whose Fiancé Refuses to Save

'Don't Blame Your Stupidity on Christianity': Dave Ramsey's Blunt Advice to a Bride Whose Fiancé Refuses to Save

The $109,000 Income Threshold That Triggers a $1,148 Medicare Surcharge Most Retirees Miss

Wall Street Just Put a Monster Target on Micron. Is the Stock Still Too Cheap?

Prediction: Elon Musk Will Target 2 Trillion-Dollar Acquisitions After the SpaceX IPO

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biotechs See Increased Short Interest Bets

Why Analysts Are Thinking M&A Is Back on the Table for Gilead

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Why Analysts Were Not Satisfied With Gilead Earnings

What to Expect From Gilead Sciences Earnings

UnitedHealth Up 22%, Leads Dow in 2016

Is This the Turning Point Puma Biotech Investors Have Waited For?

Why the Relypsa Merger Is a Great Idea

Could This Be the Turning Point for Progenics and Valeant?

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

UnitedHealth Lifts Low-End of EPS Forecast After Solid Earnings

What to Look for in Johnson & Johnson Earnings

4 Speculative Biotech and Biohealth Analysts Calls for Huge Upside

Synergy Pharmaceuticals Sinks on FDA Update

Prediction: Elon Musk Will Target 2 Trillion-Dollar Acquisitions After the SpaceX IPO

SpaceX IPOs on Friday. The 55% rule says don’t chase it.

‘Don’t Blame Your Stupidity on Christianity’: Dave Ramsey’s Blunt Advice to a Bride Whose Fiancé Refuses to Save

Featured Reads

'Don't Blame Your Stupidity on Christianity': Dave Ramsey's Blunt Advice to a Bride Whose Fiancé Refuses to Save

The $109,000 Income Threshold That Triggers a $1,148 Medicare Surcharge Most Retirees Miss